Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Tamada

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Cancer Science|April 13, 2012
DDX39 acts as a suppressor of invasion for bladder cancerMinoru Kato, Min Wei, Shotaro Yamano, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 2, 2017
Outcomes of indwelling metallic stents for malignant extrinsic ureteral obstructionJumpei Asakawa, Taro Iguchi, Satoshi Tamada, et al.
Hinyokika Kiyo. Acta Urologica Japonica|March 1, 2005
[Neuroendocrine differentiation in adenocarcinoma of prostate during combined androgen blockade therapy: a case report]Koichiro Kitamoto, Teruaki Hayashi, Satoshi Tamada, et al.
International Cancer Conference Journal|June 7, 2022
Pathologic complete response with pembrolizumab plus axitinib in metastatic renal cell carcinomaKazuki Shimizu, Satoshi Tamada, Yudai Matsuoka, et al.
Cancer Management and Research|September 15, 2018
Treatment outcomes of ureteral stenting for malignant extrinsic ureteral obstruction: a comparison between polymeric and metallic stentsJumpei Asakawa, Taro Iguchi, Satoshi Tamada, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 28, 2022
Phase I/II study of multipeptide cancer vaccine IMA901 after single-dose cyclophosphamide in Japanese patients with advanced renal cell cancer with long-term follow upFumiya Hongo, Takashi Ueda, Natsuki Takaha, et al.
International Journal of Clinical Oncology|February 12, 2019
Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: a retrospective studyTaro Iguchi, Satoshi Tamada, Minoru Kato, et al.
BMC Urology|May 26, 2011
Hyperbaric oxygen therapy for painful bladder syndrome/interstitial cystitis resistant to conventional treatments: long-term results of a case series in JapanTomoaki Tanaka, Yujiro Nitta, Kazuya Morimoto, et al.
Journal of Radiation Research|December 26, 2016
Comparative effectiveness of radical prostatectomy and curative radiotherapy in localized prostate cancer: long-term follow-upSatoshi Tamada, Noriko Ninomiya, Koichiro Kitamoto, et al.
International Journal of Clinical Oncology|May 23, 2018
Comparison of efficacy and toxicity of second-line combination chemotherapy regimens in patients with advanced urothelial carcinomaYuji Takeyama, Minoru Kato, Chikako Nishihara, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Cancer Science|April 13, 2012
DDX39 acts as a suppressor of invasion for bladder cancerMinoru Kato, Min Wei, Shotaro Yamano, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 2, 2017
Outcomes of indwelling metallic stents for malignant extrinsic ureteral obstructionJumpei Asakawa, Taro Iguchi, Satoshi Tamada, et al.
Hinyokika Kiyo. Acta Urologica Japonica|March 1, 2005
[Neuroendocrine differentiation in adenocarcinoma of prostate during combined androgen blockade therapy: a case report]Koichiro Kitamoto, Teruaki Hayashi, Satoshi Tamada, et al.
International Cancer Conference Journal|June 7, 2022
Pathologic complete response with pembrolizumab plus axitinib in metastatic renal cell carcinomaKazuki Shimizu, Satoshi Tamada, Yudai Matsuoka, et al.
Cancer Management and Research|September 15, 2018
Treatment outcomes of ureteral stenting for malignant extrinsic ureteral obstruction: a comparison between polymeric and metallic stentsJumpei Asakawa, Taro Iguchi, Satoshi Tamada, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 28, 2022
Phase I/II study of multipeptide cancer vaccine IMA901 after single-dose cyclophosphamide in Japanese patients with advanced renal cell cancer with long-term follow upFumiya Hongo, Takashi Ueda, Natsuki Takaha, et al.
International Journal of Clinical Oncology|February 12, 2019
Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: a retrospective studyTaro Iguchi, Satoshi Tamada, Minoru Kato, et al.
BMC Urology|May 26, 2011
Hyperbaric oxygen therapy for painful bladder syndrome/interstitial cystitis resistant to conventional treatments: long-term results of a case series in JapanTomoaki Tanaka, Yujiro Nitta, Kazuya Morimoto, et al.
Journal of Radiation Research|December 26, 2016
Comparative effectiveness of radical prostatectomy and curative radiotherapy in localized prostate cancer: long-term follow-upSatoshi Tamada, Noriko Ninomiya, Koichiro Kitamoto, et al.
International Journal of Clinical Oncology|May 23, 2018
Comparison of efficacy and toxicity of second-line combination chemotherapy regimens in patients with advanced urothelial carcinomaYuji Takeyama, Minoru Kato, Chikako Nishihara, et al.
Pageof 7